TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 57 filers reported holding TRINITY BIOTECH PLC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACK Asset Management | 928,000 | $10,616,000 | 4.44% |
| GOLDMAN CAPITAL MANAGEMENT INC | 350,961 | $4,015,000 | 2.86% |
| Paradice Investment Management LLC | 992,235 | $11,351,000 | 2.07% |
| Centaur Capital | 77,500 | $887,000 | 1.33% |
| Adirondack Funds | 302,305 | $3,458,000 | 1.33% |
| Adirondack Research & Management Inc. | 302,305 | $3,458,000 | 1.33% |
| RK Capital | 565,472 | $6,469,000 | 1.18% |
| Lyon Street Capital, LLC | 140,943 | $1,612,000 | 1.17% |
| Benchmark Capital Advisors | 89,941 | $1,029,000 | 0.84% |
| KEANE CAPITAL MANAGEMENT INC | 55,045 | $630,000 | 0.83% |